CXCL8 and endometriosis: Sakamoto Y demonstrated that treatment with gonadotrophin-releasing hormone agonists (GnRHa) could decrease the expression of IL-8 by inhibiting NF-κB signaling induced by TNF-α, which results in the suppression of inflammation and the development of endometriosis (124).